OPCH - Option Care Health, Inc.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Bannockburn,
United States
Type: Equity
OPCH price evolution
OPCH
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $376.87 | $219.51 | $343.85 | |
| Short term investments | ||||
| Net receivables | $428.95 | $468.3 | $573.65 | $377.66 |
| Inventory | $310.6 | $281.42 | $241.95 | $274 |
| Total current assets | $1321.37 | $1227.41 | $1129.71 | $1094.26 |
| Long term investments | ||||
| Property, plant & equipment | $215.12 | $216.65 | $208.76 | $204.79 |
| Goodwill & intangible assets | $1558.79 | $1559.56 | $1560.34 | |
| Total noncurrent assets | $2121.18 | $2119.85 | $2122.78 | |
| Total investments | ||||
| Total assets | $3427.73 | $3348.59 | $3249.56 | $3217.03 |
| Current liabilities | ||||
| Accounts payable | $591.97 | $535.69 | $485.74 | $426.51 |
| Deferred revenue | ||||
| Short long term debt | $28.46 | $25.21 | $24.28 | |
| Total current liabilities | $763.22 | $695.41 | $636.95 | $618.31 |
| Long term debt | $1105.11 | $1197.01 | $1145.49 | $1142.13 |
| Total noncurrent liabilities | $1241.75 | $1183.46 | $1177.05 | |
| Total debt | $1225.47 | $1170.7 | $1166.41 | |
| Total liabilities | $2001.5 | $1937.16 | $1820.41 | $1795.36 |
| Shareholders' equity | ||||
| Retained earnings | $609.2 | $555.35 | $502.3 | $457.51 |
| Other shareholder equity | $9.5 | $15.63 | $16.53 | $14.98 |
| Total shareholder equity | $1411.43 | $1429.15 | $1421.67 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $343.85 | $294.19 | $119.42 | $99.27 |
| Short term investments | ||||
| Net receivables | $377.66 | $377.54 | $338.24 | $328.34 |
| Inventory | $274 | $224.28 | $183.09 | $158.6 |
| Total current assets | $1094.26 | $994.34 | $710.26 | $657.01 |
| Long term investments | ||||
| Property, plant & equipment | $204.79 | $180.75 | $186.31 | $189.94 |
| Goodwill & intangible assets | $1560.34 | $1555.8 | $1499 | $1779.66 |
| Total noncurrent assets | $2122.78 | $2118.6 | $2080.66 | $1990.43 |
| Total investments | ||||
| Total assets | $3217.03 | $3112.94 | $2790.92 | $2647.44 |
| Current liabilities | ||||
| Accounts payable | $426.51 | $378.76 | $279.25 | $282.91 |
| Deferred revenue | ||||
| Short long term debt | $24.28 | $25.38 | $25.09 | $28.14 |
| Total current liabilities | $618.31 | $565.35 | $459.69 | $434.02 |
| Long term debt | $1142.13 | $1058.2 | $1134.39 | $1185.88 |
| Total noncurrent liabilities | $1177.05 | $1161.48 | $1155.34 | $1197.69 |
| Total debt | $1166.41 | $1155.03 | $1159.48 | $1214.02 |
| Total liabilities | $1795.36 | $1726.83 | $1615.03 | $1631.71 |
| Shareholders' equity | ||||
| Retained earnings | $457.51 | $190.42 | $39.87 | -$100.03 |
| Other shareholder equity | $14.98 | $21.16 | -$0.45 | -$11.17 |
| Total shareholder equity | $1421.67 | $1386.1 | $1175.89 | $1015.72 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1227.19 | $1146.05 | $1124.39 | |
| Cost of revenue | $977.82 | $907.55 | $877.27 | |
| Gross Profit | $249.37 | $238.5 | $247.12 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $153.78 | $154.74 | $147.78 | |
| Total operating expenses | $168.69 | $169.47 | $162.57 | |
| Operating income | $80.67 | $69.03 | $84.56 | |
| Income from continuing operations | ||||
| EBIT | $84.64 | $70.16 | $91.36 | |
| Income tax expense | $19 | $12.16 | $21.75 | |
| Interest expense | $12.6 | $13.2 | $12.43 | |
| Net income | ||||
| Net income | $53.04 | $44.79 | $57.18 | |
| Income (for common shares) | $53.04 | $44.79 | $57.18 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4302.32 | $3944.74 | $3438.64 | $3032.61 |
| Cost of revenue | $3321.1 | $3077.82 | $2659.03 | $2350.35 |
| Gross Profit | $981.22 | $866.92 | $779.61 | $682.26 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $607.43 | $566.12 | $525.71 | $500.2 |
| Total operating expenses | $666.63 | $626.69 | $588.76 | $571.51 |
| Operating income | $314.6 | $240.23 | $190.84 | $110.75 |
| Income from continuing operations | ||||
| EBIT | $409.99 | $259.57 | $183.5 | $102.53 |
| Income tax expense | $91.65 | $55.21 | -$23.4 | $2.83 |
| Interest expense | $51.25 | $53.81 | $67 | $107.77 |
| Net income | ||||
| Net income | $267.09 | $150.56 | $139.9 | -$8.08 |
| Income (for common shares) | $267.09 | $150.56 | $139.9 | -$8.08 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $53.04 | $44.79 | $57.18 | |
| Operating activities | ||||
| Depreciation | $20.34 | $22.97 | $19.7 | |
| Business acquisitions & disposals | $0.36 | |||
| Stock-based compensation | $7.61 | $9.61 | $7.57 | |
| Total cash flows from operations | $195.66 | -$68.78 | $50.97 | |
| Investing activities | ||||
| Capital expenditures | -$9.78 | -$5.82 | -$16.14 | |
| Investments | ||||
| Total cash flows from investing | -$25.27 | -$9.78 | -$5.82 | -$15.78 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$69.89 | -$48.23 | -$76.33 | |
| Net borrowings | $48.33 | -$1.5 | -$1.5 | |
| Total cash flows from financing | -$122.83 | -$28.52 | -$49.73 | -$77.83 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $139.18 | $157.36 | -$124.34 | -$42.64 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $267.09 | $150.56 | $139.9 | -$8.08 |
| Operating activities | ||||
| Depreciation | $80.73 | $85.15 | $83.97 | $96.71 |
| Business acquisitions & disposals | -$12.49 | -$87.36 | -$85.91 | |
| Stock-based compensation | $30.48 | $16.78 | $9.57 | $2.92 |
| Total cash flows from operations | $371.3 | $267.55 | $208.57 | $127.39 |
| Investing activities | ||||
| Capital expenditures | -$38.12 | -$20.69 | -$25.63 | -$26.88 |
| Investments | ||||
| Total cash flows from investing | -$56.51 | -$108.05 | -$111.54 | -$26.33 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$253.38 | $21.27 | -$0.03 | $118.03 |
| Net borrowings | -$6 | -$6 | -$64.04 | -$183.25 |
| Total cash flows from financing | -$265.13 | $15.27 | -$76.87 | -$68.85 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $49.66 | $174.76 | $20.16 | $32.21 |
News
Fundamentals
| Market cap | $5.35B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 170.15M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.26 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.73 |
| Quick ratio | 1.32 |